About Consensus Pharmaceuticals
Developer of peptide-based drug discovery technologies. The company makes use of its suite of functional proteomic technologies to rapidly characterize protein binding site requirements (enzyme and receptor) and to assist in cell signaling pathway placement through bioinformatics. With the successful sequencing of the human genome, development of tools to assist in understanding gene function, such as those the company offers, has become the next critical step of research efforts to identify and validate genes as targets for drug discovery. This information allows the rapid initiation of selective HTS assays and focusing of drug discovery programs. Additional the company's technology provides purified, functional G Protein-Coupled Receptors for a range of applications from crystallization studies to the identification of the native ligands of new receptors (de-orphaning) for drug discovery.